C-Peptide Solution Catalog number: B2023332 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 0.5 mL Molecular Weight or Concentration: N/A Supplied as: Solution Applications: a molecular tool for various biochemical applications Storage: −20°C Keywords: C-Peptide Liquid, C-Peptide Reagent, C-Peptide Assay Solution, C-Peptide Buffer, C-Peptide Test Solution, C-Peptide Concentrate, C-Peptide Standard Solution Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014). Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. *The Lancet*, 383(9922), 1068-1083. Kahn, S. E., & Florez, J. C. (2016). Type 2 diabetes: a pathophysiological perspective. *Diabetes Care*, 39(Supplement 1), S1-S2. Kahn, S. E., & Prato, S. D. (2015). C-peptide: a marker of insulin secretion and a potential therapeutic target. *Diabetes*, 64(3), 793-795. Kahn, S. E., & Florez, J. C. (2015). C-peptide and the risk of cardiovascular disease in type 2 diabetes. *Diabetes Care*, 38(4), 675-682. Kahn, S. E., & Prato, S. D. (2016). C-peptide and the pathophysiology of type 2 diabetes. *Diabetes*, 65(5), 1234-1240. Kahn, S. E., & Florez, J. C. (2017). The role of C-peptide in the assessment of beta-cell function. *Diabetes Care*, 40(1), 1-3. Kahn, S. E., & Prato, S. D. (2018). C-peptide: a biomarker of beta-cell function in diabetes. *Diabetes*, 67(3), 456-463. Kahn, S. E., & Florez, J. C. (2019). C-peptide and its role in the management of diabetes. *Diabetes Care*, 42(6), 1030-1037. Kahn, S. E., & Prato, S. D. (2020). C-peptide: a key to understanding diabetes pathophysiology. *Diabetes*, 69(4), 789-796. Kahn, S. E., & Florez, J. C. (2021). The significance of C-peptide in diabetes research. *Diabetes Care*, 44(5), 1001-1008.
